Simon Campbell, Abingworth Adviser and former VP for Worldwide Discovery and Medicinal R&D in Europe at Pfizer
I have worked with Abingworth for over 6 years and I admire their professional approach to biotech investments. Science and people are their key considerations, but the Abingworth team is also able to contribute management and financial skills. Abingworth takes a real interest in all the companies in their portfolio and works hard with the different management teams to translate innovative science into valuable products.
|